Coreline Soft Completes Medical AI Approval in Japan
Coreline Soft’s focus on medical AI is reaping benefits. The company recently renewed its approval with Japan’s PMDA for its AI-based software, AVIEW. This keeps Coreline Soft competitive and relevant in the healthcare tech space.
Core Features of AVIEW’s Approval
- NeuroCT: Automates the detection and visualization of potential brain hemorrhage areas in head and neck CT scans. This helps in quick decision-making in emergencies.
- LungCT: Delivers a precise analysis of lung nodules in chest CT scans, assisting in early cancer detection and follow-up evaluation.
Importance of ‘Gasan 3’ Reimbursement
Japan’s health sector holds high entry barriers for AI diagnostic solutions. Coreline Soft’s achievement in obtaining the “Gasan 3” reimbursement underscores AVIEW’s technical superiority and clinical validity.
Benefits of ‘Gasan 3’:
- Adds extra fees to the image reading system cost in Japan.
- Helps healthcare institutions recoup costs when implementing AI solutions.
Strategic Technological Enhancements
Coreline Soft incorporated VUNO Med–LungCT from VUNO, boosting its portfolio. This integration strengthens the company’s foothold in AI for chest diagnostics, enhancing market trust in Japan.
Expansion Steps:
- Securing AVIEW LCS Plus and LungCT solutions enhances their AI offerings.
- Expanding product reliability and increasing choice for Japanese users.
Insights from Coreline Soft’s Leadership
Jinkook Kim, Coreline Soft’s CEO, mentioned the new approval and reimbursement processes ensure they provide well-optimized cancer and brain hemorrhage solutions for the Japanese market. This strategy strengthens their competitive position.
Upcoming Participation in JSTR
Coreline Soft plans to attend the Japanese Society of Thoracic Radiology conference in Tokyo. This event serves as a platform to showcase their innovations and interact with industry leaders.
Highlights:
- Coreline Soft’s AVIEW reinforces its role in medical AI.
- ‘Gasan 3’ reimbursement opens market opportunities.
- Collaboration with VUNO boosts their technical edge.
Coreline Soft continues to solidify its position in medical AI with strategic moves and industry recognition.



![[South Korea] HUONS Meditech’s URO-UEMXD Expands Global Influence](https://i0.wp.com/productadvisor.com/wp-content/uploads/2024/10/huons-1.png?fit=800%2C616&ssl=1)